Could treating a common bug stop stomach cancer before it starts?
NCT ID NCT06943794
Summary
This study aims to prevent stomach cancer by identifying and treating people who carry a high-risk type of the common stomach bacteria H. pylori. It will enroll over 4,800 adults aged 40+ and follow them for 5-10 years to see if this targeted treatment strategy lowers their cancer risk compared to standard care. The goal is to create a practical, large-scale prevention program.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC (STOMACH) CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
People's Hospital of Tongling City
Tongling, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.